Post job

Amylin Pharmaceuticals's revenue is $650.7 million.

What is Amylin Pharmaceuticals's revenue?

Amylin Pharmaceuticals's annual revenue is $650.7M. Zippia's data science team found the following key financial metrics about Amylin Pharmaceuticals after extensive research and analysis.
  • Amylin Pharmaceuticals has 1,300 employees, and the revenue per employee ratio is $500,522.
  • Amylin Pharmaceuticals peak revenue was $650.7M in 2024.

On this page

Peak revenue
$650.7M (2025)
Company peak revenue
Revenue / employee
$500,522
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Peak revenue
$650.7M (2025)
Company peak revenue
Revenue / employee
$500,522
Company revenue / employee

Amylin Pharmaceuticals financing

Amylin Pharmaceuticals received early financing of $0.0 on 1990-01-01.

SeriesRound sizeDate
Venture Round - Amylin Pharmaceuticals01/1990

Amylin Pharmaceuticals investors

InvestorsSecurity type
Sequoia CapitalVenture Round - Amylin Pharmaceuticals

Amylin Pharmaceuticals competitors

Amylin Pharmaceuticals's top competitor, Johnson & Johnson, earned an annual revenue of $88.8B.

Amylin Pharmaceuticals's smallest competitor is Elan Pharmaceuticals with revenue of $6.2M last year.

Amylin Pharmaceuticals revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Amylin Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Amylin Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Amylin Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Amylin Pharmaceuticals. The data presented on this page does not represent the view of Amylin Pharmaceuticals and its employees or that of Zippia.

Amylin Pharmaceuticals may also be known as or be related to Amylin Pharmaceuticals, Amylin Pharmaceuticals Inc., Amylin Pharmaceuticals LLC, Amylin Pharmaceuticals, Inc. and Amylin Pharmaceuticals, LLC.